Max Healthcare Institute Ltd’s fundamental analysis highlights key financial metrics: Market Cap of ₹84,999.79 crore, PE Ratio of 80.37, Debt to Equity of 9.30 and Return on Equity of 16.12%. These indicators reflect the company’s financial health and market valuation.
Content:
- Max Healthcare Institute Ltd Overview
- Max Healthcare Institute Limited Financial Results
- Max Healthcare Institute Ltd Financial Analysis
- Max Healthcare Institute Limited Company Metrics
- Max Healthcare Institute Ltd Stock Performance
- Max Healthcare Institute Peer Comparison
- Max Healthcare Institute Shareholding Pattern
- Max Healthcare Institute Ltd History
- How To Invest In Max Healthcare Institute Share?
- Max Healthcare Institute Fundamental Analysis – FAQs
Max Healthcare Institute Ltd Overview
Max Healthcare Institute Ltd is an Indian healthcare company providing medical and healthcare services. It operates in the healthcare sector, offering a range of medical treatments, home care services and pathology services under various brands.
The company is listed on both the NSE and BSE. With a market capitalization of ₹84,999.79 crore, it’s currently 12.05% away from its 52-week high and 65.01% away from its 52-week low.
Max Healthcare Institute Limited Financial Results
Max Healthcare Institute Ltd’s financial performance in FY24 shows strong growth in revenue, profitability and overall financial health. The company reported significant improvements across key indicators, reflecting a solid operational base and increased efficiency in managing assets and liabilities.
1. Revenue Trend: The company’s revenue for FY24 was ₹5,406 crores, an increase from ₹4,563 crores in FY23, reflecting a solid growth trajectory.
2. Equity and Liabilities: The equity capital stood at ₹971.91 crores in FY24, up from ₹970.92 crores in FY23. Total liabilities increased to ₹12,000 crores from ₹10,102 crores.
3. Profitability: Operating profit for FY24 was ₹1,492 crores, an improvement from ₹1,241 crores in FY23, with an OPM of 26.72%, slightly higher than 26.38% in FY23.
4. Earnings per Share (EPS): The company reported an EPS of ₹10.88 in FY24, compared to ₹11.37 in FY23, showing a marginal decline despite profitability improvements.
5. Return on Net Worth (RoNW): The RoNW increased as reserves grew to ₹7,369 crores from ₹6,397 crores, reflecting better returns on shareholders’ equity.
6. Financial Position: Non-current assets rose to ₹10,294 crores from ₹8,159 crores, while current assets decreased to ₹1,706 crores in FY24, down from ₹1,943 crores in FY23, indicating efficient asset management.
Max Healthcare Institute Ltd Financial Analysis
| FY 24 | FY 23 | FY 22 | |
| Sales | 5,406 | 4,563 | 3,931 |
| Expenses | 3,914 | 3,322 | 2,989 |
| Operating Profit | 1,492 | 1,241 | 943 |
| OPM % | 26.72 | 26.38 | 23.22 |
| Other Income | 178 | 139 | 118 |
| EBITDA | 1,670 | 1,380 | 1,070 |
| Interest | 60 | 84 | 101 |
| Depreciation | 245 | 232 | 221 |
| Profit Before Tax | 1,365 | 1,064 | 739 |
| Tax % | 23 | -4 | 18 |
| Net Profit | 1,058 | 1,104 | 605 |
| EPS | 10.88 | 11.37 | 6.24 |
* Consolidated Figures in Rs. Crores
Max Healthcare Institute Limited Company Metrics
Max Healthcare Institute Ltd’s company metrics include a market capitalization of ₹84,999.79 crore, a book value per share of ₹86.5 and a face value of ₹10. With a debt-to-equity ratio of 9.30, a return on equity of 16.12% and a 0.17% dividend yield, these figures underscore the company’s financial position and investment profile.
Market Capitalization: Market Capitalization represents the total market value of Max Healthcare Institute’s outstanding shares, amounting to ₹84,999.79 crore.
Book Value: The book value per share of Max Healthcare Institute is ₹86.5, indicating the value of the company’s net assets divided by its shares outstanding.
Face Value: The face value of Max Healthcare Institute’s shares is ₹10, which is the original cost of the shares as stated on the certificate.
Asset Turnover Ratio: The asset turnover ratio of 0.58 measures how efficiently Max Healthcare Institute uses its assets to generate revenue.
Total Debt: The total debt of ₹688.96 crore represents the sum of all short-term and long-term debt obligations of Max Healthcare Institute.
Return on Equity (ROE): The ROE of 16.12% measures Max Healthcare Institute’s profitability in generating income from its equity investments.
EBITDA (Q): The quarterly EBITDA of ₹422.09 crore represents Max Healthcare Institute’s earnings before interest, taxes, depreciation and amortization.
Dividend Yield: The dividend yield of 0.17% shows the annual dividend payment as a percentage of Max Healthcare Institute’s current share price, indicating the return on investment from dividends alone.
Max Healthcare Institute Ltd Stock Performance
Max Healthcare Institute Ltd has shown impressive returns, with a one-year return on investment (ROI) of 67.6% and a three-year ROI of 36.4%. These returns indicate strong growth potential, making it a promising investment option for long-term investors.
| Period | Return on Investment (%) |
| 1 Year | 67.6 |
| 3 Years | 36.4 |
If you invest ₹1,000:
1 year ago, your investment would be worth ₹1,676.
3 years ago, your investment would have grown to ₹1,364.
Max Healthcare Institute Peer Comparison
Max Healthcare Institute Ltd, with a market cap of ₹93,611.46 crore and a P/E ratio of 88.83, stands strong with a 1-year return of 67.64%. It competes with Apollo Hospitals (38.63% return), Fortis Healthcare (82.22%) and Global Health (60.1%) in terms of profitability and growth.
| Name | CMP Rs. | Mar Cap Rs.Cr. | P/E | ROE % | EPS 12M Rs. | 1Yr return % | ROCE % | Div Yld % |
| Apollo Hospitals | 7035.9 | 101210.22 | 97.69 | 13.67 | 72.14 | 38.63 | 15.55 | 0.23 |
| Max Healthcare | 962.95 | 93611.46 | 88.83 | 13.37 | 10.84 | 67.64 | 16 | 0.16 |
| Fortis Health. | 592.95 | 44728.21 | 69.67 | 7.85 | 8.65 | 82.22 | 10.34 | 0.17 |
| Global Health | 1114.8 | 29939 | 62.07 | 17.93 | 17.97 | 60.1 | 19.32 | 0 |
| Dr Lal Pathlabs | 3236.25 | 27070.63 | 70.96 | 20.36 | 45.7 | 37.04 | 25.17 | 0.74 |
| Narayana Hrudaya | 1273.85 | 26047.72 | 32.29 | 31.43 | 39.47 | 15.88 | 26.54 | 0.31 |
| Poly Medicure | 2502.85 | 25264.05 | 93.71 | 19.08 | 28.1 | 72.1 | 23.62 | 0.12 |
Max Healthcare Institute Shareholding Pattern
Max Healthcare Institute Ltd’s shareholding pattern for June 2024 shows promoters holding 23.74%, slightly down from 23.75% in March 2024. FIIs hold a significant 56.99%, down from 57.33%. DIIs increased their stake to 15.36%, while retail and others hold 3.91%.
| All values in % | Jun-24 | Mar-24 | Dec-23 |
| Promoters | 23.74 | 23.75 | 23.75 |
| FII | 56.99 | 57.33 | 60.69 |
| DII | 15.36 | 14.96 | 11.55 |
| Retail & others | 3.91 | 3.97 | 3.99 |
Max Healthcare Institute Ltd History
Max Healthcare Institute Limited is a prominent Indian healthcare company specializing in medical and healthcare services. It operates through various segments, including hospital-based treatments, homecare services under Max@Home and pathology services through Max Lab, offering a comprehensive range of healthcare solutions.
The company excels in providing specialized treatments across multiple medical fields, including cancer care, cardiac sciences, endocrinology, ophthalmology and neurosciences. Its expertise extends to advanced procedures such as organ transplants, laparoscopic surgeries, and robotic surgeries, positioning it as a leader in cutting-edge medical care.
Max Healthcare Institute has established a significant presence across India, with 17 healthcare facilities located in Delhi, Mumbai, Punjab, Uttar Pradesh and Uttarakhand. This extensive network allows the company to cater to a wide patient base, offering high-quality healthcare services across various regions.
How To Invest In Max Healthcare Institute Share?
To invest in Max Healthcare Institute shares, open a demat account with Alice Blue. Research the company’s fundamentals, financial performance and position in the healthcare sector. Analyze historical stock data and compare it with industry peers.
Determine your investment strategy based on your financial goals and risk tolerance. Consider factors such as healthcare industry trends, government policies and the company’s expansion plans. Decide on the investment amount and timing.
Place your order through the broker’s platform. Regularly monitor your investment, staying updated on company news, quarterly results and healthcare sector trends. Consider seeking advice from a financial advisor for personalized guidance and to ensure your investment aligns with your overall portfolio strategy.
Max Healthcare Institute Fundamental Analysis – FAQs
Max Healthcare Institute Ltd’s fundamental analysis reveals a Market Cap of ₹84,999.79 crore, PE Ratio of 80.37, Debt to Equity of 9.30 and Return on Equity of 16.12%. These metrics provide insights into the company’s financial health, profitability and market valuation.
Max Healthcare Institute’s market capitalization is ₹84,999.79 crore. This figure represents the total value of the company’s outstanding shares in the stock market, calculated by multiplying the current stock price by the number of outstanding shares.
Max Healthcare Institute Limited is an Indian healthcare company providing medical and healthcare services. It operates hospitals, home care services and pathology labs, offering a wide range of specialized medical treatments and healthcare solutions across multiple locations in India.
Max Healthcare Institute is a public limited company with diverse ownership. The promoter group, including KKR, holds a significant stake. As a listed entity, ownership is distributed among various institutional and individual shareholders through stock market participation.
The main shareholders of Max Healthcare Institute Ltd include the promoter group (KKR), along with institutional investors and public shareholders. For the most current and accurate information on major shareholders, refer to the company’s latest shareholding pattern disclosure.
Max Healthcare Institute operates in the healthcare industry. The company specializes in providing medical and healthcare services, including hospital-based treatments, home care services and pathology services, catering to various medical needs across multiple specialities.
To invest in Max Healthcare Institute shares, open a demat account with Alice Blue. Research the company’s performance and healthcare sector trends. Decide on your investment strategy. Place your order through the broker’s platform. Regularly monitor your investment, staying informed about market conditions. Consider seeking financial advice for personalized guidance.
Determining if Max Healthcare Institute is overvalued or undervalued requires analyzing its financials, growth prospects, industry position, and peer comparison. Consider factors like PE ratio, future earnings potential and healthcare sector trends. Consult recent analyst reports for expert opinions on the company’s valuation.
Disclaimer: The above article is written for educational purposes and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
